Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.

Dopa-responsive dystonia (DRD) was originally described in a series of Japanese patients, but is now increasingly recognized in other countries. Recently the GTP cyclohydrolase I (GTPCH) gene was isolated as the first causative gene for dopa-responsive dystonia (DRD). Mutations were identified in three Japanese families with autosomal dominantly inherited DRD and in one sporadic Japanese patient. Characterisation of the exon-intron boundaries of this gene has now allowed the analysis of mutations at the level of genomic DNA. Amplifying all six exons, we analyzed the GTPCH gene in nine British families with 33 affected family members and in three sporadic cases and found six new mutations. Only point mutations were found, causing a stop codon in one family and an amino acid change in highly conserved regions of the gene in a further four families and in one sporadic case. None of these mutations were detected more than once and none of the mutations previously described were found in our patients. No mutations were identified in four families and in two sporadic cases.

[1]  D. Beck Dystonia Musculorum Deformans with Another Case in the Same Family , 1947, Proceedings of the Royal Society of Medicine.

[2]  A. Bagga,et al.  Progressive dystonia with marked diurnal variation , 1984, Indian journal of pediatrics.

[3]  Emma Carrick,et al.  Dopa‐responsive dystonia , 1994, Annals of neurology.

[4]  R. Huber,et al.  Atomic structure of GTP cyclohydrolase I. , 1995, Structure.

[5]  S. Matsumoto,et al.  Multiple mRNA forms of human GTP cyclohydrolase I. , 1992, Biochemical and biophysical research communications.

[6]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[7]  S. Kaufman Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. , 1959, The Journal of biological chemistry.

[8]  S. Fahn,et al.  Long‐term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa‐responsive dystonia , 1992, Annals of neurology.

[9]  S. Udenfriend,et al.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.

[10]  C. Heizmann,et al.  Human GTP-cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hybridization. , 1995, Genomics.

[11]  N. Blau,et al.  Characterization of Mouse and Human GTP Cyclohydrolase I Genes , 1995, The Journal of Biological Chemistry.

[12]  F. Wooten,et al.  Dopa-responsive dystonia , 1998, Neurology.

[13]  D. Howells,et al.  Cerebrospinal Fluid Concentrations of Pterins and Metabolites of Serotonin and Dopamine in a Pediatric Reference Population , 1993, Pediatric Research.

[14]  D. Weeks,et al.  The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q , 1995, Annals of Neurology.

[15]  J. Mallet,et al.  Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. , 1995, Human molecular genetics.